铁中介免疫微环境和治疗反应在炎症性肠病的治疗反应
Haiming Tang1, Peng Li1, Xiutian Guo1
1Department of Anorectal Surgery, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
DNA and cell biology
|November 9, 2023
概括
这项研究揭示了铁亡在炎症性肠病 (IBD) 中发挥作用,通过改变免疫微环境. 关键的铁化相关基因被确定为IBD治疗的潜在治疗标.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
背景情况:
- 炎症性肠病 (IBD) 是一种慢性胃肠道疾病,涉及免疫失调.
- 将铁与IBD病原体联系在一起的确切机制尚未完全理解.
- 研究IBD中的铁亡可能会揭示新的治疗策略.
研究的目的:
- 为了识别与ferroptosis相关的基因 (FRGs) 在IBD中差异表达.
- 探索FRG在塑造IBD免疫微环境中的作用.
- 发现基于铁亡的IBD潜在的治疗点.
主要方法:
- 在IBD与对照样本中对27个FRG的差异基因表达分析.
- 在IBD粘膜微环境中评估免疫细胞透的CIBERSORT分析.
- 共识聚类和随机森林建模以确定枢纽基因和预测模型.
- 在IBD小鼠模型中进行scRNA测序和RT-qPCR验证.
主要成果:
- 27个FRG在IBD中差异表达,M1巨细胞和中性粒细胞增加.
- 基于FRG的两个不同的集群显示了免疫细胞群的变化 (CD4 T细胞,M2巨细胞,巨细胞).
- 鉴定了23个枢纽基因,区分IBD集群与差异性免疫治疗反应;CD8+ T效应记忆细胞中的铁亡得分最高.
- 在IBD小鼠模型中验证了8个决定性基因,包括6个FRG.
结论:
- 铁亡与IBD中观察到的免疫微环境失调有关.
- 特定的FRG和枢纽基因与IBD亚型和免疫细胞改变有关.
- 已识别的与铁亡相关的基因代表了管理IBD的有前途的治疗标.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
Inflammatory Bowel Disease IV: Pharmacological Management
134
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
134
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
338
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
338
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
147
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
147
Inflammatory Response
2.1K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
122
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
122


